NCT04042038

Brief Summary

The goals of the project are 1) to understand what are the neural mechanisms involved in the psychological treatment of obsessive-compulsive disorder (OCD) in children/adolescents and adults, 2) to assess potential differences in the neural mechanisms involved in the psychological treatment of OCD between children/adolescents and adults, and 3) to assess the effectiveness of intensive CBT for children/adolescents and adults with OCD.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2019

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 30, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 1, 2019

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2023

Completed
Last Updated

March 1, 2023

Status Verified

February 1, 2023

Enrollment Period

4.1 years

First QC Date

July 30, 2019

Last Update Submit

February 28, 2023

Conditions

Keywords

Obsessive compulsive disorderIntensive cognitive-behavioral therapyNeuroimagingResponse predictionResponse mechanismsFunctional magnetic resonance imaging

Outcome Measures

Primary Outcomes (2)

  • Yale-Brown Obsessive-Compulsive Scale

    The Yale-Brown Obsessive-Compulsive Scale evaluates the severity of Obsessive Compulsive Disorder symptoms in adults. The scale is a clinician-rated, 10-item scale, each item rated from 0 (no symptoms) to 4 (extreme symptoms) (total range, 0 to 40), with separate subtotals for severity of obsessions and compulsions.

    Change from baseline to post-treatment (1 month)

  • Children´s Yale-Brown Obsessive-Compulsive Scale

    The Children´s Yale-Brown Obsessive-Compulsive Scale evaluates the severity of Obsessive Compulsive Disorder symptoms in children/adolescents. The severity of the obsessions is rated on five Severity Items for Obsessions. Each of these five items is rated on a 5-point, ordinal scale: 0 = none, 1 = mild, 2 = moderate, 3 = severe, 4 = extreme. These values are anchored by a description for each score. The Obsessions Severity Score is obtained by adding the scores for items 1 through 5 (range = 0 to 20). There are five comparable Severity Items for Compulsions (items 6 through 10), which are also scored from 0 to 4. The Compulsions Severity Score is obtained by adding the scores of items 6 through 10 (range = 0 to 20). Summing the scores for all 10 items yields the CY-BOCS Total score (range = 0 to 40).

    Change from baseline to post-treatment (1 month)

Secondary Outcomes (4)

  • Obsessive-Compulsive Inventory-Revised

    Change from baseline to post-treatment (1 month)

  • Obsessive Compulsive Inventory-Child Version

    Change from baseline to post-treatment (1 month)

  • Children's Depression Inventory

    Change from baseline to 1 month.

  • Spence Children's Anxiety Scale

    Change from baseline to 1 month

Study Arms (2)

CBT

EXPERIMENTAL

Intensive CBT (20 sessions in 1 month)

Behavioral: Cognitive-behavior therapy (psychological treatment)

Waiting-list

NO INTERVENTION

Waiting-list

Interventions

Participants will receive up to 20 hours of manualized and structured CBT based on exposure and response prevention by experienced clinicians

CBT

Eligibility Criteria

Age8 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Principal diagnosis of OCD;
  • Y-BOCS or CYBOCS ≥ 16).
  • No current psychotropic medication (except benzodiacepines for sleep). 4 ) Age between 8 and 17 years (Study 1) and between 18 and 60 years (Study 2).

You may not qualify if:

  • Current major depression or current/past psychosis, bipolar disorder or substance abuse.
  • Developmental disorders (including autistic spectrum disorders).
  • To be pregnant or during breastfeeding
  • Current CBT; nt.
  • Any severe medical disorder ;
  • Any contraindication for neuroimaging

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

IDIBELL

L'Hospitalet de Llobregat, Barcelona, 08907, Spain

RECRUITING

FIDMAG Germanes Hospitalàries

Sant Boi de Llobregat, Barcelona, 08035, Spain

RECRUITING

IDIBAPS

Barcelona, 08036, Spain

RECRUITING

Related Publications (1)

  • Hermida-Barros L, Garcia-Delgar B, Lera-Miguel S, Forcadell E, Moreno E, Prime-Tous M, Jaurrieta N, Segu X, Vilajosana E, Soriano-Mas C, de la Cruz LF, Vieta E, Radua J, Lazaro L, Fullana MA. Concentrated Cognitive-Behavior Therapy for Unmedicated Children and Adolescents With Obsessive-Compulsive Disorder in Routine Clinical Care: A Randomized Controlled Trial With a 6-Month Naturalistic Follow-up. Behav Ther. 2025 Jul;56(4):799-811. doi: 10.1016/j.beth.2025.01.001. Epub 2025 Jan 13.

MeSH Terms

Conditions

Obsessive-Compulsive Disorder

Interventions

Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

Anxiety DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Central Study Contacts

Carles Soriano-Mas, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Two separate (but methodologically identical) RCTs will be conducted, one in a sample of children/adolescents with OCD (study 1) and another in a sample of adults with OCD (study 2). Within each study, one group of age and gender-matched healthy controls will also serve as a comparison group at baseline (clinical and neuroimaging assessment). Within each study, after baseline assessment, OCD participants will be randomized to either intensive CBT or waiting list for one month. Then, OCD participants will be assessed again (clinical and neuroimaging assessment).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 30, 2019

First Posted

August 1, 2019

Study Start

May 1, 2019

Primary Completion

June 1, 2023

Study Completion

September 1, 2023

Last Updated

March 1, 2023

Record last verified: 2023-02

Locations